Lunit, abbreviated from “learning unit” is an AI software company dedicated to developing advanced medical image analytics and data-driven imaging biomarkers via cutting-edge deep-learning AI technology.
With AI, Lunit aims to make data-driven medicine the new standard of care. The company is especially focused on conquering cancer, one of the leading causes of death worldwide.
Lunit develops AI solutions for precision diagnostics and therapeutics, to find the right diagnosis at the right cost, and the right treatment for the right patients.
Shaping the future
Founded in 2013, Lunit has been internationally acknowledged for its advanced, state-of-the-art technology and its application in medical imaging. Lunit has been named by CB Insights as one of the “AI 100” startups transforming the healthcare industry and “Digital Health 150” companies. Lunit has been chosen by the World Economic Forum as one of the “Technology Pioneers” that is shaping the future.
Lunit seeks to provide AI solutions that open a new era of data-driven precision medicine. Through AI solutions for diagnostic and therapeutic biomarkers, the company aims to solve the most critical issues in cancer care, reduce medical costs and prolong survival.
Lunit’s technology has been recognized at international competitions, such as ImageNet (5th place, 2015), TUPAC 2016 (1st place), and Camelyon 2017 (1st place), surpassing top companies like Google, IBM, and Microsoft.
As a medical AI company, Lunit places great value on building clinical evidence by publishing their research in major peer-reviewed journals. Their findings in AI detection on chest x-ray and mammography are published in Radiology, The Lancet Digital Health, JAMA Network Open, Clinical Infectious Diseases, and other prestigious scientific journals.
Product profile
Lunit INSIGHT CXR is a software solution that assists physicians in the interpretation of chest radiography images. The solution has been designed to automatically analyze chest radiographs via deep-learning technology. The device helps identify abnormal-looking areas on chest radiography with 97-99% accuracy, such as: atelectasis, calcification, cardiomegaly, consolidation, fibrosis, mediastinal widening, nodule, pneumothorax, pleural effusion and pneumoperitoneum.
Validated by published clinical studies, Lunit INSIGHT CXR can improve a physician’s reading performance, especially for critical and urgent findings such as nodule, pneumoperitoneum, pneumothorax, and consolidation.
Relying on its proven accuracy, a physician can focus specifically on abnormalities, ultimately saving time and addressing the excessive workload and shortage of radiologists in chest X-ray interpretation.
Lunit INSIGHT MMG
Lunit INSIGHT MMG is a software solution that assists physicians in the interpretation of mammograms. The device has been designed to automatically analyze digital mammograms via deep-learning technology.
The device identifies and classifies suspect areas for breast cancer on mammograms with 96% accuracy. The solution enables visualization and quantitative estimation of the likelihood of the presence of a malignant lesion.
Validated by published clinical studies, Lunit INSIGHT MMG can improve a physician’s diagnostic performance especially for dense breast and early breast cancers.
Based on its proven accuracy, physicians can reduce false-negative cases and recall rates, which ultimately addresses the shortage of mammography specialists in a single-and double-reading environment.
- For more information, visit: https://www.lunit.io/en
